CRHR1 and inflammatory bowel disease: Further, testing in control rats indicates good safety profiles [37,43], and suggests that CRH-R1 antagonists may improve upon IBD and IBS current treatments by dealing with GI dysfunction and stress levels without the need for polypharmacy.